Advanced search
Publication Cover
Expert Review of Cardiovascular Therapy Volume 13, 2015 - Issue 6
Submit an article Journal homepage
2,535
Views
13
CrossRef citations to date
0
Altmetric
Editorials

Does influenza vaccination influence cardiovascular complications?

Jacob A UdellWomen’s College Research Institute and Cardiovascular Division, Department of Medicine, Women’s College Hospital, Toronto, ON, Canada;Peter Munk Cardiac Centre, University Health Network, Toronto, ON, Canada;Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Toronto, ON, Canada;Institute for Clinical Evaluative Sciences, Toronto, ON, Canada;Heart and Stroke Richard Lewar Centre of Excellence in Cardiovascular Research, University of Toronto, Toronto, ON, CanadaCorrespondence[email protected].
,
Michael E FarkouhPeter Munk Cardiac Centre, University Health Network, Toronto, ON, Canada;Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Toronto, ON, Canada;Heart and Stroke Richard Lewar Centre of Excellence in Cardiovascular Research, University of Toronto, Toronto, ON, Canada
,
Scott D SolomonCardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
&
Orly VardenySchool of Pharmacy, University of Wisconsin, Madison, WI, USA
Pages 593-596 | Published online: 14 May 2015

References

  • Mertz D, Kim TH, Johnstone J, et al. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ 2013;347:f5061
  • Sandoval C, Walter SD, Krueger P, et al. Risk of hospitalization during influenza season among a cohort of patients with congestive heart failure. Epidemiol Infect 2007;135(4):574-82
  • Smeeth L, Thomas SL, Hall AJ, et al. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 2004;351(25):2611-18
  • Warren-Gash C, Smeeth L, Hayward AC. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis 2009;9(10):601-10
  • Corrales-Medina VF, Alvarez KN, Weissfeld LA, et al. Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease. JAMA 2015;313(3):264-74
  • Paddock CD, Liu L, Denison AM, et al. Myocardial injury and bacterial pneumonia contribute to the pathogenesis of fatal influenza B virus infection. J Infect Dis 2012;205(6):895-905
  • Yende S, D’Angelo G, Kellum JA, et al. Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis. Am J Respir Crit Care Med 2008;177(11):1242-7
  • Fagnoul D, Pasquier P, Bodson L, et al. Myocardial dysfunction during H1N1 influenza infection. J Crit Care 2013;28(4):321-7
  • Udell JA, Zawi R, Bhatt DL, et al. Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. JAMA 2013;310(16):1711-20
  • Veljkovic V, Glisic S, Veljkovic N, et al. Influenza vaccine as prevention for cardiovascular diseases: possible molecular mechanism. Vaccine 2014;32(48):6569-75
  • Bermudez-Fajardo A, Oviedo-Orta E. Influenza vaccination promotes stable atherosclerotic plaques in apoE knockout mice. Atherosclerosis 2011;217(1):97-105
  • Liu WM, van der Zeijst BA, Boog CJ, et al. Aging and impaired immunity to influenza viruses: implications for vaccine development. Hum Vaccin 2011;7(Suppl):94-8
  • Haq K, McElhaney JE. Immunosenescence: Influenza vaccination and the elderly. Curr Opin Immunol 2014;29:38-42
  • Vardeny O, Sweitzer NK, Detry MA, et al. Decreased immune responses to influenza vaccination in patients with heart failure. J Cardiac Fail 2009;15(4):368-73
  • Keshtkar-Jahromi M, Vakili H, Rahnavardi M, et al. Antibody response to influenza immunization in coronary artery disease patients: a controlled trial. Vaccine 2009;28(1):110-13
  • Van Ermen A, Hermanson MP, Moran JM, et al. Double dose vs. standard dose influenza vaccination in patients with heart failure: a pilot study. Eur J Heart Fail 2013;15(5):560-4
  • DiazGranados CA, Dunning AJ, Kimmel M, et al. Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med 2014;371(7):635-45
  • DiazGranados CA, Dunning AJ, Jordanov E, et al. High-dose trivalent influenza vaccine compared to standard dose vaccine in elderly adults: safety, immunogenicity and relative efficacy during the 2009-2010 season. Vaccine 2013;31(6):861-6

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.